Literature DB >> 3791211

Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.

S Noguchi, Y Nishizawa, N Nakamura, N Uchida, K Yamaguchi, B Sato, Y Kitamura, K Matsumoto.   

Abstract

Shionogi carcinoma 115 (SC115) had been accepted for 20 years as an androgen-dependent mouse mammary tumor, the growth of which is stimulated only by androgen. However, we very recently found that the growth of SC115 tumors in vivo is stimulated not only by physiological doses of androgen but also by pharmacological doses of estrogen through the estrogen receptor system. In the present study, the growth-stimulative effect of estrogen on an androgen-dependent cloned cell line (SC-3) derived from SC115 cells, which showed androgen- and estrogen-dependent growth in vivo, was examined in vitro. In serum-supplemented medium (Eagle's minimum essential medium containing 2% steroid-free fetal calf serum), testosterone or 5 alpha-dihydrotestosterone (10(-9)-10(-6) M) significantly stimulated the growth of SC-3 cells (3.2-fold increase in cell number at day 10 in culture containing 10(-8) M androgens) and changed the shape of SC-3 cells from epithelial to spindle (fibroblast-like), whereas 17 beta-estradiol (10(-12)-10(-6) M) even in high concentrations had no such effects on SC-3 cells. Contrary to the effect of 17 beta-estradiol in vivo, 17 beta-estradiol as well as cyproterone acetate (10(-8)-10(-6) M) inhibited the growth-stimulative effect of testosterone (10(-8) M) on SC-3 cells in a dose-dependent manner in the serum-supplemented medium. The anti-androgen and 17 beta-estradiol also showed comparable competitive effects on [3H]testosterone binding to androgen receptor in SC-3 cells. In serum-free medium [Ham's F-12:Eagle's minimum essential medium (1:1, v/v) containing 0.2% bovine serum albumin], testosterone [10(-8) M] also markedly stimulated the growth of spindle-shaped SC-3 cells, and epidermal growth factor (1 ng/ml) enhanced the growth-stimulative effect of testosterone, whereas 17 beta-estradiol (10(-8)-10(-6) M) in the absence or presence of epidermal growth factor had no growth-stimulative effect on SC-3 cells. We conclude that the growth of SC115 cells is stimulated by either physiological doses of androgen or pharmacological doses of estrogen in vivo but only by androgen in cell culture.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3791211

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.

Authors:  T Yamaguchi; K Kawamoto; N Uchida; K Uchida; S Watanabe
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

2.  Facilitation of autonomous phenotype acquisition in androgen-dependent Shionogi carcinoma 115 cells by transfection of androgen-induced growth factor expression vector.

Authors:  Y Miyashita; M Koga; H Kouhara; A Tanaka; T Kishimoto; B Sato
Journal:  Jpn J Cancer Res       Date:  1994-11

3.  Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115).

Authors:  S Noguchi; Y Nishizawa; K Motomura; H Inaji; S Imaoka; H Koyama; K Matsumoto
Journal:  Jpn J Cancer Res       Date:  1993-06

4.  Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).

Authors:  M Q Fujita; T Yasui; B Sato; N Uchida; K Uchida; O Shiratori; K Takeda; K Matsumoto
Journal:  Jpn J Cancer Res       Date:  1992-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.